CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for JW Holdings Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

JW Holdings Corp
JW Office, 38, Gwacheon-daero 7-gil
Phone: +82 28406777p:+82 28406777 GWACHEON, 13840  South Korea Ticker: 096760096760
Business Summary
JW Holdings Corp is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment is involved in the manufacturing and sale of pharmaceuticals. Its major products include antibiotics, antifungal agents, blood and body fluids substitutes, hyperlipidemia drugs, electrolyte additives, angina pills, and digestive medicines. The Medical Equipment segment manufactures and sells medical equipment such as diagnostic equipment, diagnostic reagents, surgical operating tables, and surgical mooyoung lamp. The Holding Business segment manages affiliated companies within the group. The Other segment is involved in the manufacturing and sale of automotive supplies, as well as the real estate investment.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
3845 Electromedical and electrotherapeutic apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3714 Motor vehicle parts and accessories
6512 Operators of nonresidential buildings
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Honorary Chairman Jong HoLee 89 1/1/2021 1/1/2021
Co-Chief Executive Officer, Director Seong GwonHan 64 1/1/2021 2/16/2011
Co-Chief Executive Officer, Director Gyeong HaLee 58 1/1/2021
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
JW Life Science Corp 28, Hanjin 1-gil, Songak-eup DANGJIN South Korea

Business Names
Business Name
096760
Choongwae Holdings Co., Ltd
JW Life Science Corporation

General Information
Number of Employees: 161 (As of 12/31/2015)
Outstanding Shares: 70,728,275 (As of 9/30/2024)
Shareholders: 15,156
Stock Exchange: KRX
Fax Number: +82 28437696


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024